A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia

Table 1

Clinical and demographic characteristics of AIDS-PCP patients investigated in this study, China, 2013-2018.

Demographic data	Patients, no.			value
	Total patients ()	Combined echinocandins ()	Noncombined echinocandins ()
Sex (M/F)	112/10	45/7	67/3	0.096
Age (y)				0.462
Recent CD4 count (cells/μL)				0.275
Number of hospitalization days				0.409
Treatment
TMP-SMX (80 mg-400 mg, tid)	122	52	70	NA
Clindamycin (800 mg, q8h)	122	52	70	NA
Echinocandins (50 mg, qd)	52	52	0	NA
Glucocorticoid (40 mg, bid)	122	52	70	NA
Clinical outcome
PaO2/FiO2> 200 mmHg/PaO2/FiO2 ≤ 200 mmHg	100/22	45/7	55/15	0.258
Survival/death	103/19	47/5	56/14	0.118